We recently reported that sleep disorders are significantly associated with fatigue in multiple sclerosis (MS).
Objective:
The objective of this paper is to assess the effects of sleep disorder treatment on fatigue and related clinical outcomes in MS.
Methods:
This was a controlled, non-randomized clinical treatment study. Sixty-two MS patients completed standardized questionnaires including the Fatigue Severity Scale (FSS), Multidimensional Fatigue Inventory (MFI), Epworth Sleepiness scale (ESS) and Pittsburgh Sleep Quality Index (PSQI), and underwent polysomnography (PSG). Patients with sleep disorders were offered standard treatment. Fifty-six subjects repeated the questionnaires after ≥ three months, and were assigned to one of three groups: sleep disorders that were treated (SD-Tx, n=21), sleep disorders remaining untreated (SD-NonTx, n=18) and no sleep disorder (NoSD, n=17).
Results:
FSS and MFI general and mental fatigue scores improved significantly from baseline to follow-up in SD-Tx (p <0.03), but not SD-NonTx or NoSD subjects. ESS and PSQI scores also improved significantly in SD-Tx subjects (p <0.001). Adjusted multivariate analyses confirmed significant effects of sleep disorder treatment on FSS (-0.87, p = 0.005), MFI general fatigue score (p = 0.034), ESS (p = 0.042) and PSQI (p = 0.023).
Conclusion:
Treatment of sleep disorders can improve fatigue and other clinical outcomes in MS.
Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: Evidence-based management strategies for fatigue in multiple sclerosis. Washington, D.C.: Paralyzed Veterans of America, 1998.
2.
KosDKerckhofsENagelsG. Origin of fatigue in multiple sclerosis: Review of the literature. Neurorehabil Neural Repair2008; 22: 91–100.
3.
JongbloedLDisability incomes: The experiences of women with multiiple sclerosis. Occupational Therapy and Physiotherapy1998; 65: 193–201.
4.
TrojanDAArnoldDColletJP. Fatigue in multiple sclerosis: Association with disease-related, behavioural and psychosocial factors. Mult Scler2007; 13: 985–995.
5.
KaminskaMKimoffRJSchwartzmanK. Sleep disorders and fatigue in multiple sclerosis: Evidence for association and interaction. J Neurol Sci2011; 302: 7–13.
6.
KaminskaMKimoffRBenedettiA. Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler. [Epub ahead of print].
7.
VeauthierCRadbruchHGaedeG. Fatigue in multiple sclerosis is closely related to sleep disorders: A polysomnographic cross-sectional study. Mult Scler2011; 17: 613–622.
8.
TrojanDKaminskaMBar-OrA. Polysomnographic measures of disturbed sleep are associated with reduced quality of life in multiple sclerosis. J Neurol Sci2012; 316: 158–163.
9.
McDonaldWICompstonAEdanG. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol2001; 50: 121–127.
10.
KurtzkeJF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology1983; 33: 1444–1452.
11.
KruppLBLaRoccaNGMuir-NashJ. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol1989; 46: 1121–1123.
12.
SmetsEMGarssenBCullA. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer1996; 73: 241–245.
13.
PutzkiNKatsaravaZVagoS. Prevalence and severity of multiple-sclerosis-associated fatigue in treated and untreated patients. Eur Neurol2008; 59: 136–142.
14.
DittnerAJWesselySCBrownRGThe assessment of fatigue: A practical guide for clinicians and researchers. J Psychosom Res2004; 56: 157–170.
15.
GoligherECPouchotJBrantR. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol2008; 35: 635–642.
16.
SchneiderRAReliability and validity of the Multidimensional Fatigue Inventory (MFI-20) and the Rhoten Fatigue Scale among rural cancer outpatients. Cancer Nurs1998; 21: 370–373.
17.
JohnsMWA new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep1991; 14: 540–545.
18.
BuysseDJReynoldsCFMonkTH. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res1989; 28: 193–213.
19.
AllenRPPicchiettiDHeningWA. Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med2003; 4: 101–119.
20.
WaltersASLeBrocqCDharA. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med2003; 4: 121–132.
21.
HublinCKaprioJPartinenM. The prevalence of narcolepsy: An epidemiological study of the Finnish Twin Cohort. Ann Neurol1994; 35: 709–716.
22.
American Academy of Sleep Medicine. The international classification of sleep disorders. Diagnostic & coding manual. 2nd ed.Westchester, IL: American Academy of Sleep Medicine, 2005.
23.
RadloffLSThe CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Measure1977; 1: 385–401.
24.
WareJESnowKKKosinkiK. SF-36 Health survey: Manual and interpretation guide. Boston: Nimrod Press, 1993.
25.
WareJEKosinskiMBjornerJ. SF-36v2 health survey: A primer for healthcare providers. Lincoln, RI: Quality Metric Inc, 2008.
26.
IberCAncoli-IsraelSChessonA. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1st ed.Westchester, IL: American Academy of Sleep Medicine, 2007.
27.
LittnerMRKushidaCWiseM. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep2005; 28: 113–121.
28.
American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. Sleep1999; 22: 667–689.
29.
KushidaCAChediakABerryRB. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med2008; 4: 157–171.
30.
MorgenthalerTIAuroraRNBrownT. Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: An update for 2007. An American Academy of Sleep Medicine report. Sleep2008; 31: 141–147.
31.
DingliKColemanELVennelleM. Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J2003; 21: 253–259.
32.
SkomroRPGjevreJReidJ. Outcomes of home-based diagnosis and treatment of obstructive sleep apnea. Chest2010; 138: 257–263.
33.
PitsonDJStradlingJRAutonomic markers of arousal during sleep in patients undergoing investigation for obstructive sleep apnoea, their relationship to EEG arousals, respiratory events and subjective sleepiness. J Sleep Res1998; 7: 53–59.
34.
KushidaCALittnerMRHirshkowitzM. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep2006; 29: 375–380.
LittnerMRKushidaCAndersonWM. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep2004; 27: 557–559.
37.
AuroraRNZakRSMagantiRK. Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med2010; 6: 85–95.
38.
BenjaminiYHochbergYControlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc B1995; 57: 289–300.
39.
PunjabiNMThe epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc2008; 5: 136–143.
40.
KohnenRAllenRPBenesH. Assessment of restless legs syndrome—methodological approaches for use in practice and clinical trials. Mov Disord2007; 22 Suppl18: S485–S494, S485–S494.
41.
AbetzLArbuckleRAllenRP. The reliability, validity and responsiveness of the International Restless Legs Syndrome Study Group rating scale and subscales in a clinical-trial setting. Sleep Med2006; 7: 340–349.
